These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 19690987)

  • 1. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
    Wu HQ; Pereira EF; Bruno JP; Pellicciari R; Albuquerque EX; Schwarcz R
    J Mol Neurosci; 2010 Jan; 40(1-2):204-10. PubMed ID: 19690987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
    Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
    Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
    Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
    Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.
    Konradsson-Geuken A; Wu HQ; Gash CR; Alexander KS; Campbell A; Sozeri Y; Pellicciari R; Schwarcz R; Bruno JP
    Neuroscience; 2010 Sep; 169(4):1848-59. PubMed ID: 20600676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.
    Alexander KS; Wu HQ; Schwarcz R; Bruno JP
    Psychopharmacology (Berl); 2012 Apr; 220(3):627-37. PubMed ID: 22038535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
    Bortz DM; Wu HQ; Schwarcz R; Bruno JP
    Neuropharmacology; 2017 Jul; 121():69-78. PubMed ID: 28419874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.
    Beggiato S; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K; Schwarcz R; Ferraro L
    Eur J Neurosci; 2013 May; 37(9):1470-7. PubMed ID: 23442092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ
    Secci ME; Mascia P; Sagheddu C; Beggiato S; Melis M; Borelli AC; Tomasini MC; Panlilio LV; Schindler CW; Tanda G; Ferré S; Bradberry CW; Ferraro L; Pistis M; Goldberg SR; Schwarcz R; Justinova Z
    Mol Neurobiol; 2019 May; 56(5):3563-3575. PubMed ID: 30151725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory.
    Pocivavsek A; Wu HQ; Potter MC; Elmer GI; Pellicciari R; Schwarcz R
    Neuropsychopharmacology; 2011 Oct; 36(11):2357-67. PubMed ID: 21796108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
    Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
    Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
    Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
    J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
    Schilström B; Ivanov VB; Wiker C; Svensson TH
    Neuropsychopharmacology; 2007 Jan; 32(1):43-53. PubMed ID: 16641937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine.
    Alexander KS; Pocivavsek A; Wu HQ; Pershing ML; Schwarcz R; Bruno JP
    Neuroscience; 2013 May; 238():19-28. PubMed ID: 23395862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat.
    Rassoulpour A; Wu HQ; Albuquerque EX; Schwarcz R
    Neuropsychopharmacology; 2005 Apr; 30(4):697-704. PubMed ID: 15496939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential Disruption of Prefrontal GABAergic Function by Nanomolar Concentrations of the α7nACh Negative Modulator Kynurenic Acid.
    Flores-Barrera E; Thomases DR; Cass DK; Bhandari A; Schwarcz R; Bruno JP; Tseng KY
    J Neurosci; 2017 Aug; 37(33):7921-7929. PubMed ID: 28729445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of GABAergic inputs to CA1 pyramidal neurons by nicotinic receptors and kynurenic acid.
    Banerjee J; Alkondon M; Pereira EF; Albuquerque EX
    J Pharmacol Exp Ther; 2012 May; 341(2):500-9. PubMed ID: 22344459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.
    Akagbosu CO; Evans GC; Gulick D; Suckow RF; Bucci DJ
    Schizophr Bull; 2012 Jun; 38(4):769-78. PubMed ID: 21172906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in extracellular kynurenic acid concentrations in rat prefrontal cortex after D-kynurenine infusion: an in vivo microdialysis study.
    Ogaya T; Song Z; Ishii K; Fukushima T
    Neurochem Res; 2010 Apr; 35(4):559-63. PubMed ID: 19941066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.
    Lopes C; Pereira EF; Wu HQ; Purushottamachar P; Njar V; Schwarcz R; Albuquerque EX
    J Pharmacol Exp Ther; 2007 Jul; 322(1):48-58. PubMed ID: 17446300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.